Cannabis Corner: These pot stocks make the right moves

Article Excerpt

First, the good news: cannabis legalization will eventually lead to some great business successes. The bad news is that only a few of the multitude of cannabis stocks today will pay off for investors. Consumer cannabis demand is high, but growing and distributing it across multiple markets is more difficult. With “Cannabis Corner,” we focus on quality stocks that are most likely to emerge as winners in the “Wild West” of marijuana investing. VIVO CANNABIS $0.18 (Toronto symbol VIVO; TSINetwork Rating: Speculative) (vivocannabis.com; Shares o/s: 367.1 million; Market cap: $66.1 million; TSI Cannabis Quality Rating [CQR]:) lets you tap premium cannabis production in Canada. Vivo’s Vanluven facility in Napanee, Ontario has now received EU-GMP (European Union Good Manufacturing Practices) certification from Germany’s health authority. The certification will let Vivo, through its ABcann Medicinals subsidiary, export product for sale into European and other markets that require cannabis to be manufactured under the rigorous GMP standards. At the same time Vivo’s German subsidiary, Beacon Medical Germany, received…